Since aberrant c-Myc activation drives key gene networks contributing to the pathogenesis of many human cancers5, and an increasing number of lncRNAs have been found to be involved in c-Myc-mediated signaling23, we sought to identify lncRNA effectors downstream of c-Myc that may play roles in cancer development and progression in the pan-cancer context. Here, MYC is linked to cancer.